Ranbaxy Laboratories
BSE: 500359 | NSE: RANBAXY | ISIN: INE015A01028 | Pharmaceuticals
Competition
| Last Price | Market Cap. (Rs. cr.) |
Sales Turnover |
Net Profit | Total Assets | |
| Sun Pharma | 1,653.90 | 34,254.98 | 3,861.55 | 1,265.29 | 5,175.02 |
| Cipla | 316.30 | 25,396.40 | 5,270.54 | 767.83 | 5,290.99 |
| Dr Reddys Labs | 1,217.00 | 20,546.01 | 4,197.53 | 560.89 | 5,899.40 |
| Ranbaxy Labs | 471.80 | 19,840.29 | 4,782.76 | 571.98 | 7,442.15 |
| GlaxoSmithKline | 1,707.00 | 14,458.81 | 1,892.96 | 512.29 | 1,764.57 |
| Lupin | 1,581.75 | 14,066.61 | 2,967.13 | 416.97 | 2,320.21 |
| Cadila Health | 798.00 | 10,892.62 | 1,945.72 | 265.91 | 2,052.70 |
| Piramal Health | 414.00 | 8,653.14 | 2,333.46 | 275.32 | 2,165.88 |
| Divis Labs | 618.50 | 8,100.96 | 1,203.49 | 421.26 | 1,314.44 |
| Glenmark | 234.90 | 6,335.30 | 856.11 | 217.93 | 2,291.33 |



Offline






